After-Hours Stock Movers

CureVac N.V. (Nasdaq: CVAC) 10% LOWER; announced results from the final analysis of its 40,000 subject international pivotal Phase 2b/3 study (the HERALD study) of the first-generation COVID-19 vaccine candidate, CVnCoV. In the unprecedented context of 15 strains circulating within the study population at the time of final analysis, CVnCoV demonstrated an overall vaccine efficacy of 48% (vaccine 83 vs. 145 placebo) against COVID-19 disease of any severity, including single non-respiratory mild symptoms. Significant protection was demonstrated among participants in the age group of 18 to 60, with an efficacy of 53% (vaccine 71 vs. 136 placebo) against disease of any severity and across all 15 identified strains; protection against moderate to severe disease was calculated to be 77% (9 vaccine vs. 36 placebo). In the same age group, CVnCoV provided 100% protection (vaccine 0 vs. 6 placebo) against hospitalization or death. In participants above 60 years, who represented 9% of the analysed cases, the available data did not enable a statistically significant determination of efficacy. The data confirm the favorable safety profile of CVnCoV in all age groups. The study will continue to complete follow-up analyses for trial participants. Available data have been communicated to the European Medicines Agency (EMA).

Franklin Covey Co. (NYSE: FC) 6.7% HIGHER; Sales Increase to Record Third Quarter Level of $58.7 Million

Passage Bio Inc. (NASDAQ: PASG) 3.5% HIGHER; Raymond James initiates coverage with an Outperform rating and a price target of $29.00.

Didi (NYSE: DIDI) 3.3% HIGHER; rises after gaining just 1% in its IPO debut Wednesday.

DHC Acquisition (NASDAQ: DHCA) 2% HIGHER; FreeWire Technology, an EV charging a power startup, is in talks to go public through a merger with DHCA.

Micron Technology (NASDAQ: MU) 1.8% LOWER; reported Q3 EPS of $1.88, $0.17 better than the analyst estimate of $1.71. Revenue for the quarter came in at $7.42 billion versus the consensus estimate of $7.23 billion. Micron Technology sees Q4 2021 EPS of $2.20-$2.40, versus the consensus of $2.18. Micron Technology sees Q4 2021 revenue of $8-8.4 billion, versus the consensus of $7.86 billion.

ContextLogic Inc. (NASDAQ: WISH) 1.4% LOWER; announced that Chief Financial Officer Rajat Bahri has notified the Board of Directors that he plans to resign from his position effective July 23. The company has engaged executive search firm Heidrick and Struggles to identify Mr. Bahris successor.

Realty Income Corporation (NYSE: O) 1% LOWER; announced that it has commenced an underwritten public offering of 7,250,000 shares of common stock. The company also plans to grant the underwriters a 30-day option to purchase up to an additional 1,087,500 shares of common stock. The joint book-running managers for the offering are Wells Fargo Securities and Morgan Stanley.